ICS Maugeri

Pavia, Italy Founded: 1965 • Age: 61 yrs
Specialized healthcare services and advanced medical technologies are provided.

About ICS Maugeri

ICS Maugeri is a company based in Pavia (Italy) founded in 1965. Specialized healthcare services and advanced medical technologies are provided. ICS Maugeri has raised $59.97 million across 5 funding rounds from investors including European Union and Trilantic Europe. Its chief executive, as recorded, is Paolo Migliavacca. Its website icsmaugeri.it draws about 73 thousand monthly visits. Its legal entity is Istituti Clinici Scientifici Maugeri Spa Società Benefit.

Company details

ICS Maugeri was founded in 1965 in Pavia, Italy, and operates within the healthcare sector. Services encompass rehabilitative cardiology, neuro-motor rehabilitation, pulmonology, diagnostics, palliative care, and oncology treatments. Research on rare diseases is conducted, while advanced robotic technology is applied in rehabilitative processes. Multiple facilities are maintained, supported by a network of medical professionals, with patient access facilitated through online scheduling and centralized booking.

  • Headquarters Pavia, Italy
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website icsmaugeri.it
  • Social LinkedIn Facebook
  • Legal Name Istituti Clinici Scientifici Maugeri Spa Società Benefit
Key Metrics
  • Total Equity Funding
    $59.97M (USD)

    in 5 rounds

  • Latest Funding Round
    $183.15K (USD), Grant

    Apr 2021

  • Investors

Funding Insights of ICS Maugeri

ICS Maugeri has successfully raised a total of $59.97M across 5 strategic funding rounds. The most recent funding activity was a Grant round of $183.15 thousand completed in April 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $59.97M
  • Total Rounds 5
  • Last Round Grant — $183,153
  • First Round $59.97M

    (Oct 2016)

  • Investors Count 2

All 5 funding rounds of ICS Maugeri with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2021$183,153Grant––
Mar 2021$231,620Grant––
Jan 2020$477,927Grant––
Jan 2018$216,197Grant––
Oct 2016$59.97MPrivate Equity Round–Trilantic Europe
–
Valuation history

2 investors in total: 2 institutional.

Investors in ICS Maugeri

ICS Maugeri has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union and Trilantic Europe.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
PE firm invests in Europe
trilanticeurope.comLondon, United Kingdom
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Premium access

Investor details for ICS Maugeri

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of ICS Maugeri

31 people are tracked at ICS Maugeri (7 in leadership, 24 in team).

NameRoleGroup
Paolo Migliavacca
CEOLeadership
Mario Melazzini
CEOLeadership
Laura Adelaide Dalla Vecchia
Medical DirectorLeadership
Carlo Morasso
Head Of LaboratoryLeadership
Francesco Benini
Head Of HR OperationsLeadership
Franco Balestrieri
Communication E Media Relations DirectorLeadership
Gianluca Carenzo
Director Outpatient Clinics AreaLeadership
Luigi Zanchi
Responsabile Amministrativo - DirigenteTeam
Letizia Capoti
Specialista AmministrativoTeam
Monica Golfari
Insurance And Funds Manager, Strategy And Business DevelopmentTeam
Fabio Plano
FisioterapistaTeam
Lucia Angelini M.D.
Pain Medicine PhysicianTeam
Valeria de Grazia
GeriatraTeam
Marta Sacchi
Medico Specialista In Medicina Del LavoroTeam
Benedetto Calì
Dirigente Medico Chirurgo Generale (chirurgia Endocrina)Team
Petronilla Battista
NeuropsychologistTeam
Marta Truffi
ResearcherTeam
Gianvito Lagravinese
PsicologoTeam
Christos Nektarios Kotzaloizoglou
Medico Di GuardiaTeam
Maria Tuttolomondo
ControllerTeam

11 more people are available in the full profile.

Premium access

Complete people profiles for ICS Maugeri

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of ICS Maugeri

3 dated milestones of ICS Maugeri across 56 years, from founding to its latest funding, stage changes and deals.

  1. Founded ICS Maugeri is founded.
  2. Funding First funding round of $60.0M.
  3. Funding Latest funding round, Grant, of $183K.

Web traffic of ICS Maugeri

The website of ICS Maugeri (icsmaugeri.it) receives about 73.3K visits a month.

  • Monthly visits
    73.3K

    ▲ 9% vs previous month

Similar websites

Websites whose visitors overlap most with ICS Maugeri. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
msdmanuals.com
100%
14.1M#4,038View details
medicalimaging.it
medicalimaging.it
95%
#677,481–
aiponet.it
aiponet.it
94%
#1,707,613–
humanitas.it
94%
2.9M#23,062View details
htcnet.it
htcnet.it
90%
#2,206,285–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 40 similar websites and full traffic analytics for ICS Maugeri

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about ICS Maugeri

ICS Maugeri was founded in 1965 and raised its 1st funding round 51 years after it was founded.

ICS Maugeri is headquartered in Pavia, Italy. It is registered at Pavia, Lombardy, Italy.

Paolo Migliavacca is the CEO of ICS Maugeri, as recorded in our data.

ICS Maugeri is a funded company, having raised a total of $59.97M across 5 funding rounds to date. The company's 1st funding round was a Private Equity Round of $59.97M, raised on Oct 2016.

ICS Maugeri was founded in 1965 in Pavia, Italy, and operates within the healthcare sector. Services encompass rehabilitative cardiology, neuro-motor rehabilitation, pulmonology, diagnostics, palliative care, and oncology treatments. Research on rare diseases is conducted, while advanced robotic technology is applied in rehabilitative processes. Multiple facilities are maintained, supported by a network of medical professionals, with patient access facilitated through online scheduling and centralized booking.

ICS Maugeri has 2 investors. Key investors include European Union, and Trilantic Europe.

ICS Maugeri operates through Istituti Clinici Scientifici Maugeri Spa Società Benefit.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available